Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Diabetes Mellitus, Adult-Onset”

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02524782
What this trial is testing

A Phase 1, Single- and Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MEDI4166 in Subjects With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
MedImmune LLC 103
Large-scale testing (Phase 3)Ended earlyNCT01609582
What this trial is testing

Study of TAK-875 in Adults With Type 2 Diabetes and Cardiovascular Disease or Risk Factors for Cardiovascular Disease

Who this might be right for
Type 2 DiabetesCardiovascular Disease
Takeda 3,207
Not applicableStudy completedNCT04536480
What this trial is testing

Time Limited Eating in Adolescents With Type 2 Diabetes (KT2D)

Who this might be right for
Pediatric ObesityType 2 DiabetesTime Restricted Eating
Children's Hospital Los Angeles 87
Post-approval studies (Phase 4)Study completedNCT02299388
What this trial is testing

To Evaluate the Effect of Liraglutide on Ambulatory Blood Pressure-A Pilot Study

Who this might be right for
Diabetes Mellitus, Non-Insulin-DependentHypertensive Disease
Tulane University School of Medicine 11
Not applicableEnrolling By InvitationNCT05766488
What this trial is testing

Assessing Continuous Glucose Monitor Use in Underserved Primary Care Patients

Who this might be right for
Type 2 Diabetes
University of Nebraska 50
Not applicableStudy completedNCT01050803
What this trial is testing

Effectiveness of the Farsi Diabetes Self-management Education (FDSME) Program for People With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
Tehran University of Medical Sciences 280
Testing effectiveness (Phase 2)Study completedNCT00842361
What this trial is testing

Comparison of NN5401 Versus Biphasic Insulin Aspart 30 on a Twice Daily Regimen in Subjects With Type 2 Diabetes Mellitus

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 66
Not applicableStudy completedNCT04914559
What this trial is testing

Glucose Response in Persons with Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Société des Produits Nestlé (SPN) 16
Not applicableStudy completedNCT02506296
What this trial is testing

Glucose Response, Excursions And Treatment (GREAT) Study

Who this might be right for
Type 2 Diabetes
Royal Devon and Exeter NHS Foundation Trust 53
Post-approval studies (Phase 4)UnknownNCT01001962
What this trial is testing

Double Blind Placebo Study of JARDIANCE® (Empagliflozin) in Prehypertensives Type II Diabetics

Who this might be right for
HypertensionType II Diabetes
Aristotle University Of Thessaloniki 1,054
Large-scale testing (Phase 3)Not Yet RecruitingNCT07487103
What this trial is testing

Efficacy and Safety of QLG1091 vs Rybelsus as add-on to Metformin in Subjects With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Qilu Pharmaceutical Co., Ltd. 478
Not applicableStudy completedNCT06085703
What this trial is testing

Effects of Henagliflozin on the Brain Function in T2DM Patients With Mild Cognitive Impairment: a Randomized, Parallel Controlled Clinical Trial

Who this might be right for
Type 2 Diabetes MellitusMild Cognitive Impairment
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 24
Large-scale testing (Phase 3)Study completedNCT06323161
What this trial is testing

A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes Treated With Once-daily Basal Insulin With or Without Metformin

Who this might be right for
Type 2 Diabetes
Novo Nordisk A/S 274
Not applicableStudy completedNCT07260201
What this trial is testing

Triglyceride-Glucose and TGI-BMI Indices Compared With HOMA-IR

Who this might be right for
Insulin ResistanceObesity Type 2 Diabetes Mellitus
Hisar Intercontinental Hospital 150
Not applicableStudy completedNCT01963130
What this trial is testing

Does Vildagliptin Affect Portal Vein Pressure In Patients With Type 2 Diabetes Mellitus? A Cross Sectional Study

Who this might be right for
Drug MechanismDrug Usage
Bezmialem Vakif University 97
Post-approval studies (Phase 4)Study completedNCT00913367
What this trial is testing

Efficacy/Safety Study of Amaryl®M 1/500 mg Twice Daily Versus Amaryl® 4 mg Both in Combination With Lantus® in Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
Handok Inc. 110
Testing effectiveness (Phase 2)Looking for participantsNCT07693036
What this trial is testing

HUC-MSC-Exosomes for T2DM - Safety & Efficacy

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
Peking University First Hospital 66
Not applicableNot Yet RecruitingNCT07595887
What this trial is testing

Ultrasound Assessment of Sciatic Nerve and Inferior Gluteal Artery in Diabetic Peripheral Neuropathy(DPN): Association With a Target Gene

Who this might be right for
Diabetic Peripheral Neuropathy (DPN)
Second Hospital of Shanxi Medical University 120
Not applicableStudy completedNCT04214704
What this trial is testing

Assessing the Benefits of a Painless Lancing Device Among Diabetes Patients

Who this might be right for
Type 1 DiabetesType 2 Diabetes
Jothydev's Diabetes and Research Centre 110
Not applicableUnknownNCT03787563
What this trial is testing

Herbal Tea in the Treatment of Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
Composite Interceptive Med Science 10
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation